Mirum Pharmaceuticals (MIRM) Other financing activities (2020 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Other financing activities of $259.9 million for Q1 2026, up 3987.88% year-over-year from $6.4 million in Q1 2025, and up 934.69% quarter-over-quarter from -$31.1 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Other financing activities (2020 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Other financing activities history runs 7 years deep, the most recent figure standing at $259.9 million for Q1 2026.
- In Q1 2026, Other financing activities rose 3987.88% year-over-year to $259.9 million; the TTM figure through Mar 2026 stood at $253.6 million (up 1009.65% YoY), while the FY2024 annual figure was $17.7 million, down 91.25% from the prior year.
- Other financing activities for Q1 2026 stood at $259.9 million, up from -$31.1 million in the prior quarter.
- The five-year high for Other financing activities was $259.9 million in Q1 2026, with the low at -$31.1 million in Q4 2025.
- The 5-year median for Other financing activities is $5.3 million (2024), against an average of $27.9 million.
- The sharpest annual moves came in 2025 and 2026: Other financing activities sank 683.2% in 2025, then soared 3987.88% in 2026.
- Mirum Pharmaceuticals' Other financing activities stood at -$2.0 million in 2022, then jumped by 92.15% to -$159000.0 in 2023, then jumped by 3458.49% to $5.3 million in 2024, then tumbled by 683.2% to -$31.1 million in 2025, then soared by 934.69% to $259.9 million in 2026.
- Business Quant data shows MIRM's Other financing activities at $259.9 million in Q1 2026, -$31.1 million in Q4 2025, and $16.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259.95 Mn |
| Mar 31, 2026 | 259.95 Mn |
| Dec 31, 2025 | -31.14 Mn |
| Dec 31, 2025 | -31.14 Mn |
| Sep 30, 2025 | 16.10 Mn |
| Sep 30, 2025 | 16.10 Mn |
| Jun 30, 2025 | 8.69 Mn |
| Jun 30, 2025 | 8.69 Mn |
| Mar 31, 2025 | 6.36 Mn |
| Mar 31, 2025 | 6.36 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 7.29 Mn |
| Jun 30, 2024 | 7.29 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | -159,000.00 |
| Dec 31, 2023 | -159,000.00 |